Reaction
Syphilis reporting signals
As of the last recalculation, Syphilis appears in 718 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is EMTRICITABINE AND TENOFOVIR ALAFENAMIDE (PRR 96.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Emtricitabine And Tenofovir Alafenamide | 36 | 96.8 | 97.2 |
| Dolutegravir Sodium | 26 | 86.7 | 86.9 |
| Darunavir | 36 | 72.6 | 72.8 |
| Ritonavir | 60 | 64.9 | 65.0 |
| Ritonavir 100 Mg | 31 | 62.8 | 63.0 |
| Cabotegravir | 16 | 58.7 | 58.8 |
| Raltegravir | 24 | 43.6 | 43.6 |
| Lopinavir And Ritonavir | 18 | 39.5 | 39.5 |
| Efavirenz | 14 | 37.1 | 37.2 |
| Atovaquone | 10 | 36.5 | 36.5 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 52 | 35.6 | 35.6 |
| Abacavir Sulfate | 11 | 33.2 | 33.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 11 | 32.2 | 32.2 |
| Atazanavir | 15 | 30.9 | 30.9 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 18 | 29.5 | 29.5 |
| Nevirapine | 9 | 29.3 | 29.3 |
| Lamivudine | 29 | 28.3 | 28.3 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 27.2 | 27.2 |
| Fluticasone Furoate | 11 | 26.7 | 26.7 |
| Lamivudine Oral | 22 | 26.0 | 26.0 |
| Febuxostat Tablets 40 Mg | 8 | 23.1 | 23.1 |
| Febuxostat Tablets 80 Mg | 8 | 23.1 | 23.1 |
| Zidovudine | 9 | 19.7 | 19.8 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 5 | 16.2 | 16.2 |
| Entecavir | 6 | 15.0 | 15.0 |
| Tenofovir Disoproxil Fumarate | 16 | 14.3 | 14.3 |
| Ethyl Alcohol | 8 | 8.6 | 8.6 |
| Paliperidone Palmitate | 6 | 5.4 | 5.4 |